drugset
drugset / Trial / NCT04538820

Dexamethasone Dose for Postoperative Nausea and Vomiting Prophylaxis in Obese Patients

NCT04538820 ↗

Phase 4 Unknown 150 enrolled Diskapi Yildirim Beyazit Education and Research Hospital
RandomizedCrossoverDouble-blindPrevention

Summary

compare the effectiveness of different doses of dexamethasone used for postoperative nausea and vomiting prophylaxis in obese patients and in normal weight patients.

Timeline

Start
2021-03-01
Primary completion
2021-09-30
Completion
2021-09-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dexamethasone Small molecule 4 mg Intravenous
Comparator Dexamethasone Small molecule 8 mg Intravenous

Indications

No indication recorded.